<DOC>
	<DOCNO>NCT00684775</DOCNO>
	<brief_summary>The purpose study determine whether employment-based naltrexone treatment prove effective promote depot naltrexone adherence drug abstinence .</brief_summary>
	<brief_title>Employment-Based Depot Naltrexone Clinical Trial II</brief_title>
	<detailed_description>A randomize study plan evaluate effectiveness employment-based reinforcement promote depot naltrexone adherence opiate-dependent adult . Vivitrol , extended-release depot formulation naltrexone approve FDA treatment alcohol dependence , use . Participants offer inpatient opioid detoxification oral naltrexone induction . Participants complete oral naltrexone induction ( N=40 ) randomly assign one two group . Both group invite work Therapeutic Workplace prescribe depot naltrexone 6 month . Participants `` Work Plus Naltrexone Contingency '' condition earn access work earn salary take depot naltrexone injection per month . `` Work Plus Naltrexone Prescription '' participant encourage take depot naltrexone monthly , access work earn salary contingent .</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Applicants blind full detail eligibility criterion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2008</verification_date>
</DOC>